BRAF and melanoma: On co-induction of activating EGFR and BRAF events in the same cell, it has been shown that exogenous expression of wild-type EGFR in a Melanoma cell line with native BRAFV600E leads to decreased proliferation of these cells in a dose-dependent manner, in-vitro and in-vivo203.